<DOC>
	<DOCNO>NCT00466401</DOCNO>
	<brief_summary>The aim study Estimate reduction LDL ezetimibe hypercholesterolemic patient simvastatin.Investigate effect LDL lower ezetimibe platelet activity LDL tendency peroxidation hypercholesterolemic patient simvastatin therapy The hypothesis : 1 . LDL lower ezetimibe on-top simvastatin patient fix dose simvastatin reduce platelet aggregation , due potential decreasing cholesterol content platelet membrane . 2 . LDL lower ezetimibe low LDL tendency peroxidation .</brief_summary>
	<brief_title>Effect Ezetimibe Platelet Aggregation LDL Tendency Peroxidation</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>1 . Hypercholesterolemic patient stable simvastatin dose least one month . 2 . Age ≥18 year stable AHA step 1 diet . 3 . Patients without CHD one risk factor ; LDL &gt; 130 mg/dL Patients CHD CHD risk equivalent ( clinical manifestation noncoronary form atherosclerotic disease ) 2 risk f actor ( cigarette smoking , hypertension ( BP ≥140/90 mm Hg antihypertensive medication ) , low HDL cholesterol ( &lt; 40 mg/dL ) , family history premature CHD ; LDL &gt; 100 mg/dL 4 . Patients ` least simvastatin treatment 20 mg per day . 5 . CPK , ALT AST &lt; 1.5 X upper limit normal baseline . 1 . Women currently receive cyclical hormone . 2 . Treatment psyllium , fiber base laxative , phytosterol margarine , OTCs affect serum lipid , unless treat stable regimen &gt; 6 week patient agrees continue regimen duration trial . 3 . Oral corticosteroid unless use replacement therapy pituitary/adrenal disease stable regimen least 6 week . 4 . Lipid lower agent include fish oil QUESTRAN take within 6 week . 5 . Active coronary heart disease : unstable angina , acute myocardial infarction , CABG PTCA within last 3 month . 6 . Women childbearing potential unless safe contraception . 7 . Psychiatric disease defect judgement . 8 . Severe renal hepatic disease . 9 . Uncontrolled hypo hyperthyroidism . 10 . Contraindication ezetimibe simvastatin treatment . The patient continue treatment simvastatin 6 week , patient treat dose simvastatin combine ezetimibe 10 mg/day 6 week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>